Active Ingredient History
Bone marrow is a semi-solid tissue found within the spongy portions of bones. In birds and mammals, bone marrow is the primary site of new blood cell production. It is composed of hematopoietic cells, marrow adipose tissue, and supportive stromal cells. In adult humans, bone marrow is primarily located in the ribs, vertebrae, sternum, and bones of the pelvis. Bone marrow comprises approximately 5% of total body mass in healthy adult humans, such that a man weighing 73 kg (161 lbs) will have around 3.7 kg (8 lbs) of bone marrow. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia, Aplastic (Phase 3)
Anemia, Sickle Cell (Phase 2)
Autoimmune Diseases (Phase 2)
Bone Marrow Transplantation (Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
Bronchiectasis (Phase 2)
Burkitt Lymphoma (Phase 3)
Cardiomyopathy, Dilated (Phase 2)
Cerebellar Diseases (Phase 2)
Craniofacial Abnormalities (Phase 2)
Encephalitis (Phase 2)
Epidermolysis Bullosa (Phase 2)
Facial Injuries (Phase 2)
Facial Transplantation (Phase 2)
Fanconi Anemia (Phase 2/Phase 3)
Fractures, Ununited (Phase 1/Phase 2)
Fusion Proteins, bcr-abl (Phase 2)
Graft Survival (Phase 2)
Graft vs Host Disease (Phase 3)
Head and Neck Neoplasms (Phase 2)
Heart Failure (Phase 2)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2)
HIV Infections (Phase 1)
Hodgkin Disease (Phase 3)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 2)
Kidney Transplantation (Phase 2)
Lambert-Eaton Myasthenic Syndrome (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Liver Neoplasms (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 2)
Myasthenia Gravis (Phase 2)
Myeloablative Agonists (Phase 2)
Myelodysplastic Syndromes (Phase 4)
Myeloproliferative Disorders (Phase 2)
Neoplasms (Phase 2)
Neuroblastoma (Phase 2)
Neuromyelitis Optica (Phase 2)
Opsoclonus-Myoclonus Syndrome (Phase 2)
Organ Transplantation (Phase 2)
Osteoarthritis (Phase 2/Phase 3)
Osteogenesis Imperfecta (Phase 1)
Osteopetrosis (Phase 2/Phase 3)
Ovarian Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 1)
Pseudarthrosis (Phase 1/Phase 2)
Retinoblastoma (Phase 2)
Sarcoma (Phase 2)
Scleroderma, Systemic (Phase 1/Phase 2)
Sclerosis (Phase 1/Phase 2)
Severe Combined Immunodeficiency (Phase 1/Phase 2)
Spinal Fusion (Phase 4)
Stiff-Person Syndrome (Phase 2)
Testicular Neoplasms (Phase 2)
Traumatology (Phase 2)
Ulcer (Phase 1)
Vasculitis, Central Nervous System (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
